Young cancer patients undergoing cancer treatment face a 50% risk of ovarian failure and loss of fertility. Preserving ovarian function before treatment has therefore become a critical issue. Doctors highlight that traditional egg-freezing or embryo-freezing techniques are unsuitable for cancer patients because these methods require ovarian stimulation and waiting 10 to 14 days for egg retrieval, which is impractical for patients needing immediate cancer treatment. In contrast, ovarian tissue freezing can be performed promptly before cancer treatment through surgery, preserving ovarian tissue for future transplantation.
Ovarian tissue freezing offers new fertility hope for cancer patients. This technology allows ovarian tissue to be preserved and transplanted after cancer treatment, restoring ovarian function and enabling natural conception. Globally, tens of thousands of ovarian tissue freezing cases have been reported, with hundreds of cancer patients successfully giving birth to healthy babies using this method. The live birth rate is approximately 30%. More importantly, ovarian tissue freezing not only preserves fertility but also maintains the hormonal function of the ovaries, allowing patients to regain regular menstrual cycles post-recovery and preventing premature menopause.
Cancer radiation and chemotherapy drugs can cause ovarian failure. (Image provided by Heho Health)
This technology is especially suitable for young girls facing cancer treatment before puberty, as they are not yet producing mature eggs, making egg freezing impossible. Ovarian tissue freezing becomes the only option. Overall, ovarian tissue freezing offers cancer patients hope of regaining fertility after overcoming the disease. It is particularly helpful for those requiring rapid treatment and represents a groundbreaking fertility preservation technique.
This article is authorized by Heho Health.
